Showing results (21-30 of 45) with videos related to
Sort By:
Pageof 5
Annals of Surgical Oncology|June 4, 2026
Bilateral Wilms Tumor: Looking for the Best Surgical StrategyMarta Martos Rodríguez, Hélène Sudour-Bonnange, Hubert Ducou Le Pointe, et al.Pediatric Blood & Cancer|July 2, 2013
Thymus and mediastinal node involvement in childhood Langerhans cell histiocytosis: long-term follow-up from the French national cohortStephane Ducassou, Fanny Seyrig, Caroline Thomas, et al.British Journal of Haematology|April 6, 2026
Neurofilament as a biomarker of neurodegeneration in childhood Langerhans cell histiocytosis: A feasibility study on 273 patientsSolenne Le Louet, Camille Brunaud, Mohamed Barkaoui, et al.Pediatric Blood & Cancer|October 10, 2024
Li-Fraumeni-associated osteosarcomas: The French experienceEmilie Saucier, Gaëlle Bougeard, Anne Gomez-Mascard, et al.European Journal of Cancer (Oxford, England : 1990)|March 15, 2024
Chemo-immunotherapy with dinutuximab beta in patients with relapsed/progressive high-risk neuroblastoma: does chemotherapy backbone matter?Patricia Raiser, Gudrun Schleiermacher, Marion Gambart, et al.British Journal of Haematology|June 9, 2016
Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30-year nationwide cohort of 1478 patients under 18 years of ageCharlotte Rigaud, Mohamed A Barkaoui, Caroline Thomas, et al.British Journal of Haematology|July 24, 2020
Long-term follow-up of children with risk organ-negative Langerhans cell histiocytosis after 2-chlorodeoxyadenosine treatmentMohamed-Aziz Barkaoui, Emma Queheille, Nathalie Aladjidi, et al.Neuro-Oncology|August 2, 2024
Postzygotic mosaicism of SMARCB1 variants in patients with rhabdoid tumors: A not-so-rare condition exposing to successive tumorsGrégory Thomson, Mathilde Filser, Léa Guerrini-Rousseau, et al.Journal of the Endocrine Society|May 21, 2020
Pheochromocytoma and Paraganglioma in Children and Adolescents: Experience of the French Society of Pediatric Oncology (SFCE)Marie de Tersant, Lucile Généré, Claire Freyçon, et al.The Lancet. Child & Adolescent Health|December 6, 2021
Decision-tree derivation and external validation of a new clinical decision rule (DISCERN-FN) to predict the risk of severe infection during febrile neutropenia in children treated for cancerMathilde Delebarre, Fanny Gonzales, Hélène Behal, et al.Pageof 5